Screener
Beam Therapeutics BEAM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
FAQ
- What is Beam Therapeutics's invested capital?
- Beam Therapeutics (BEAM) reported invested capital of $1.13B in Q1 2026.
- How has Beam Therapeutics's invested capital changed year-over-year?
- Beam Therapeutics's invested capital increased by 48.3% year-over-year, from $759.7M to $1.13B.
- What is the long-term trend for Beam Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Beam Therapeutics's invested capital has grown at a 41.9% compound annual growth rate (CAGR), from $191.03M to $1.1B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Beam Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude